Switch View
© Newsfile
29.08.2025
ISIN: CA88337V1004
Theralase Technologies Inc.
TLT
LISTED
TSX
Theralase(R) Extends Warrants
News Preview
Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses, is pleased to announce that...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US8791051043
abrdn Healthcare Opportunities Fund
THQ
LISTED
NYSE
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
News Preview
PHILADELPHIA, Aug. 29, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, THQ), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on August 29, 2025, on a per share basis to all shareholders of record as of August 22, 2025 (ex-dividend date August...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US29446K1060
Equillium Inc
EQ
LISTED
NASDAQ
Equillium to Participate in the Cantor Global Healthcare Conference 2025
News Preview
Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Friday, September 5, 2025 at 7:55am ET.
Members of the Equillium management team will be a...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
29.08.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
News Preview
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.08.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
News Preview
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial treatment of 18 months...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US4579852082
Integra Lifesciences Holdings Corp
IART
LISTED
NASDAQ
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
News Preview
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare conferences:...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.08.2025
ISIN: CA3617932015
GLG Life Tech Corporation
GLG
LISTED
TSX
GLG Life Tech Corporation Reports 2025 Second Quarter Financial Results
News Preview
VANCOUVER, BC / ACCESS Newswire / August 29, 2025 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and six months ended June 30, 2025. The complete set of financ...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: CA98420N1050
Xenon Pharmaceuticals Inc.
XENE
LISTED
NASDAQ
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
VANCOUVER, British Columbia and BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to seven new non...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors – SMLR
News Preview
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Semler Scientific investors under the fed...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US88033G4073
Tenet Healthcare Corp
THC
LISTED
NYSE
Tenet to Participate in the 2025 Wells Fargo Healthcare Conference
News Preview
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 9:30 a.m. Eastern Time.
A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The replay w...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US1508377066
CEL-SCI Corp
CVM
LISTED
XASE
CEL-SCI Announces Closing of $10 Million Public Offering
News Preview
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the closing of its offering of 1,111,200 shares of its common stock. Each share of common stock was sold at a public offering price of $9.00 per share. Total gross proceeds from the offering, before deducting the pl...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Aug. 29, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BIOHAVEN LTD. (BHVN), CONTACT THE LAW O...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
29.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages LifeMD, Inc. (LFMD) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”). LifeMD investors have until October 27, 2025 to file a lead plaintiff motion.
IF YOU AR...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
CNC Deadline: Rosen Law Firm Urges Centene Corporation (NYSE: CNC) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025. Centene describes itself as a “leading healthcare enterprise.”
For more information, submit a form, email attorney Phill...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic executives to speak at upcoming investor conferences
News Preview
GALWAY, Ireland, Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences:
2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive offic...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic executives to speak at upcoming investor conferences
News Preview
GALWAY, Ireland, Aug. 29, 2025 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences:
2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive officer, and...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.08.2025
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - von First Berlin Equity Research GmbH
29.08.2025 / 16:48 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Au......
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2025
ISIN: CA52731E1060
Leveljump Healthcare Corp.
JUMP
LISTED
TSX
LevelJump Announces 2025 Second Quarter Results
News Preview
Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months and six months ended June 30, 2025.Financial and Operational HighlightsRevenues were $4.7 million in the second quarter compared to $4.4 mill...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: VGG1110E1079
Biohaven Ltd
BHVN
LISTED
NYSE
BHVN Deadline: Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025. Biohaven describes itself as a “biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, ne...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Faruqi & Faruqi Reminds Biohaven Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2025 - BHVN
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Biohaven To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 in Biohaven between March 24, 2023 and May 14, 2025 and would like to discuss your legal rights, call Faruqi &am...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Faruqi & Faruqi Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 - CNC
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Centene between December 12, 2024 and June 30, 2025 and would like to discuss your legal rights, call Faruqi &...
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2025
ISIN: CA90468F1027
Unidoc Health Corp.
UDOC
LISTED
CSE
CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 29 août/August 2025) - Effective immediately, UniDoc Health Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. _________________________________ Avec effet immédiat, UniDoc Health Corp. sera réi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.08.2025
ISIN: US14757U2087
CASI Pharmaceuticals, Inc.
CASI
LISTED
NASDAQ
CASI Pharmaceuticals Announces Second Quarter 2025 Business and Financial Results
News Preview
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 29, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today reported business and financial results for the quarter ended June 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2025
News Preview
Aggregated presentation by day and by market Statement of transactions in own shares from August 18th to August 22nd 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US00166B1052
ALX Oncology Holdings Inc
ALXO
LISTED
NASDAQ
ALX Oncology to Participate in Upcoming Investor Conferences in September
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in both the C...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: FR0000032526
Guerbet SA
GBT
LISTED
EURONEXT
Évolutions au sein du Comité exécutif
News Preview
Changes within the Executive Committee...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
News Preview
Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless of symptoms.
The guidelines enable a proactive approach to disease management and underscore that intervention should be considered for asymptomat...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US42226A1079
Healthequity Inc
HQY
LISTED
NASDAQ
HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education
News Preview
Industry Leader’s HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions Industry Leader’s HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Viracor BioPharma Announces Relocation to New State-of-the-Art Facility
News Preview
Eurofins Viracor BioPharma Services, a recognized leader in analytical testing and clinical trial services, announces the infrastructure enhancement of its headquarters and laboratory operations to a new, custom-built 96,000 sq. ft. facility in Lenexa, Kansas, scheduled for completion in September 2025. This strategic move, although only a few mil...
Themefolio
Profiler
Peergroup
© ActuNews
29.08.2025
ISIN: FR0000061129
Boiron SA
BOI
LISTED
EURONEXT
BOIRON : Déclaration des droits de vote au 31 juillet 2025
News Preview
Le 29 août 2025
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF)
Date d'arrêt des informations
Nombre total d'actions composant le capital
Nombre total...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US92337F1075
Veracyte Inc
VCYT
LISTED
NASDAQ
Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
Veracyte, Inc. (Nasdaq: VCYT) announced today that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025, at 4:50 p.m. Eastern Time.
A live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at http://investor.veracyte....
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Provides Update on Patent Litigation with NeoGenomics
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today provided an update regarding its intellectual property litigation with NeoGenomics, Inc.
The U.S. District Court for the Middle District of North Carolina issued a ruling invalidating certain claims in two patents that Natera asserted against NeoGenomics’...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
News Preview
Navitor is now approved as a minimally invasive alternative to surgery for patients in Europe with symptomatic, severe aortic stenosis (a common and life-threatening heart valve disease) who are at low or intermediate surgical riskCE Mark is based on safety and effectiveness data from the VANTAGE trial presented at the European Society of Cardi...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare unveils Vivid Pioneer, its most advanced AI-powered cardiovascular ultrasound system, designed to enhance speed and image quality for improved diagnostic confidence and workflow efficiency
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely redesigned to support clinicians with extraordinary imaging in 2D, 4D and color flow, streamlined workflow, and enhanced diagnostic confidence. The ultrasound system recently...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025
News Preview
Bristol Myers Squibb (NYSE: BMY) today presented results from COLLIGO-HCM, a global retrospective real-world data study, in an oral session at the European Society of Cardiology (ESC) Congress 2025 in Madrid, Spain. The analysis showed that Camzyos (mavacamten) was associated with reductions in left ventricular outflow tract (LVOT) obstruction and...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio to Present at Upcoming Investor Conferences
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Company will present at the following...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera
News Preview
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the District Court for the Middle District of North Carolina has granted NeoGenomics’ motion for summary judgment that all of Natera’s asserted patent claims are invalid for claiming ineligible subject matter. The Cou...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s operations during a fireside chat session at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York.
The session will take...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025.
The company will take part in a fireside chat beginning at 8:30 a.m. ET.
Investors and the general public are invited to listen to the session by visiting http://investo...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US70261F1030
Pasithea Therapeutics Corp.
KTTA
LISTED
NASDAQ
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Pasithea Tx (Nasdaq: KTTA) to present PAS-004 clinical progress at H.C. Wainwright Global Investment Conference on Sept. 8, 2025 in NYC....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day
News Preview
GAITHERSBURG, Md., Aug. 29, 2025 (GLOBE NEWSWIRE) -- In honor of International Overdose Awareness Day (IOAD) on August 31, Emergent BioSolutions (NYSE: EBS) is re-launching its Ready to Rescue public education campaign, which raises awareness of opioid emergencies and the importance of being prepared with NARCAN® Nasal Spray among young adults at...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US45166A1025
IDEAYA Biosciences Inc
IDYA
LISTED
NASDAQ
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 28, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to pu...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
News Preview
– Bempedoic Acid Receives Strongest Endorsement from ESC/EAS Guidelines Based on Compelling and Practice-Changing Evidence –...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart Granted Extension by Nasdaq to Regain Compliance
News Preview
- Company must regain compliance with the Nasdaq Bid Price Rule on or before the October 17, 2025 deadline -...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
News Preview
BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be par...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US1569441009
CG Oncology, Inc.
CGON
LISTED
NASDAQ
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
News Preview
IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
News Preview
DUBLIN, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
News Preview
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), followi...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US00289Y1073
Abeona Therapeutics Inc
ABEO
LISTED
NASDAQ
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
News Preview
CLEVELAND, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2025:...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US0223071020
Alumis, Inc.
ALMS
LISTED
NASDAQ
Alumis to Participate in Upcoming September Investor Conferences
News Preview
Alumis management will participate in several healthcare conference upcoming in September...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US04335A1051
Arvinas, Inc.
ARVN
LISTED
NASDAQ
Arvinas to Participate in Upcoming Investor Conferences
News Preview
NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in fireside chats at two upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US28617K1016
Eledon Pharmaceuticals, Inc.
ELDN
LISTED
NASDAQ
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
News Preview
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: CA2059531020
Conavi Medical Corp
CNVI
LISTED
TSX
Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights
News Preview
TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced its financial results for the fisc...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US03152W1099
Amicus Therapeutics Inc
FOLD
LISTED
NASDAQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
News Preview
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
News Preview
SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from the Oxford University-led Active Monitoring for AtriaL FIbrillation (AMALFI) randomized clinical trial, presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the Journal of the American Med...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.08.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Last Chance to Bid on Memorabilia from Jordan, Kobe, Maradona, Ronaldo, LeBron, Yao Ming and More at Infinite Auctions
News Preview
MESA, ARIZONA / ACCESS Newswire / August 29, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its wholly owned subsidiary, Infinite Auctions, is urging collectors and sports fans worldwide to visit www.infiniteauctions.com for a rare opportunity to bid on some of the most iconic game-worn items in sports history."The...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- As per 29 August 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares, of which 356,000,049 are common shares and 1,412,788 are C-shares. The total number of votes is 356,141,327,8. The increase in the number of shares and votes results from issues of...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- As per 29 August 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares, of which 356,000,049 are common shares and 1,412,788 are C-shares. The total number of votes is 356,141,327,8. The increase in the number of shares and votes results from issues of...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Wolf Lehmann übernimmt zum 1. September 2025 CFO-Position bei Gerresheimer
News Preview
Wolf Lehmann übernimmt zum 1. September 2025 CFO-Position bei GerresheimerInternational erfahrener Finanzexperte tritt Nachfolge von Dr. Bernd Metzner an
Düsseldorf, 29. August 2025. Der Aufsichtsrat der Gerresheimer AG hat Wolf Lehmann zum Chief Financial Officer (CFO) bestellt. Er folgt zum 1. September 2025 auf Dr. Bernd Metzner, der Gerreshe......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025
News Preview
Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025
Internationally experienced finance expert to succeed Dr. Bernd Metzner
Duesseldorf, August 29, 2025. The Supervisory Board of Gerresheimer AG has appointed Wolf Lehmann as Chief Financial Officer (CFO). He will succeed Dr. Bernd Metzner on September 1, 2025, who is leavi......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
